Why, and how, is there such a giant chasm between what is being offered to cancer patients in standard care versus what is actually possible in 2025?
In this video, you'll hear from Dr. Anthony Magliocco – a Pathologist, Professor of Oncology and Pathology, and CEO of Protean BioDiagnostics – about the gap between the treatments and diagnostics accessible through public healthcare compared to the far more effective treatment options and diagnostic tools available through the newest advancements in science-based medicine.
You can watch our full interview with Dr. Magliocco and CTOAM co-founder, Michelle Morand, here ???? https://youtu.be/5VHxl5vUD8U
This is why cancer advocacy matters so much!
➡️ Don’t waste time on the wrong treatment. Find out what is best for you and how to get your doctor to prescribe it – book your Complete Treatment Options Review with specialist Alex Rolland and his team today: https://www.ctoam.com/consultation ????
***
Other ways to learn more about your cancer care options:
➡️ Book a free introductory call with Michelle to learn more about how precision cancer medicine works and how it may benefit you: https://www.ctoam.com/free-strategy-session
➡️ Want to learn how to access the newest treatments through your current doctor?
Join our (free) online Self-Advocacy training program: https://help.ctoam.com/just-the-facts
***
CTOAM is a worldwide, Canadian-based personalized cancer care and precision oncology service specializing in getting our client's rapid access to the best possible cancer treatment available for their form of cancer, while assisting their physicians in having the most current data from which to make confident treatment decisions on your behalf.
We facilitate access to peer-reviewed, science-based precision diagnostics such as PET/CT scans, liquid biopsy (blood-based genetic tests) and detailed genetic panels. We use these leading diagnostic tools, combined with a thorough and personalized research review, as our team explores the most advanced scientific data available today to find the best options for you.
Other ways to stay in touch with CTOAM:
Facebook: https://www.facebook.com/CancerTreatmentOptionsandManagement/
LinkedIn: https://www.linkedin.com/company/ctoam
Twitter: https://twitter.com/CTOAM
Blog: https://research.ctoam.com/
LinkedIn (Liquid Biopsy Labs): https://www.linkedin.com/company/13063544
LBL Twitter: https://twitter.com/LiquidBiopsyNow
Disclaimer:
Please understand that these videos are meant for educational purposes only. These videos are not intended to diagnose or be used as treatment advice. Viewers are encouraged to speak with their doctor or healthcare professionals for medical advice and before making any changes to their healthcare based on this information. All statements made in this video regarding medical treatments and health conditions are sourced and have been approved by the U.S. Food and Drug Administration (FDA). Watching this video is not a substitute for professional medical advice or a diagnosis.
In this video, you'll hear from Dr. Anthony Magliocco – a Pathologist, Professor of Oncology and Pathology, and CEO of Protean BioDiagnostics – about the gap between the treatments and diagnostics accessible through public healthcare compared to the far more effective treatment options and diagnostic tools available through the newest advancements in science-based medicine.
You can watch our full interview with Dr. Magliocco and CTOAM co-founder, Michelle Morand, here ???? https://youtu.be/5VHxl5vUD8U
This is why cancer advocacy matters so much!
➡️ Don’t waste time on the wrong treatment. Find out what is best for you and how to get your doctor to prescribe it – book your Complete Treatment Options Review with specialist Alex Rolland and his team today: https://www.ctoam.com/consultation ????
***
Other ways to learn more about your cancer care options:
➡️ Book a free introductory call with Michelle to learn more about how precision cancer medicine works and how it may benefit you: https://www.ctoam.com/free-strategy-session
➡️ Want to learn how to access the newest treatments through your current doctor?
Join our (free) online Self-Advocacy training program: https://help.ctoam.com/just-the-facts
***
CTOAM is a worldwide, Canadian-based personalized cancer care and precision oncology service specializing in getting our client's rapid access to the best possible cancer treatment available for their form of cancer, while assisting their physicians in having the most current data from which to make confident treatment decisions on your behalf.
We facilitate access to peer-reviewed, science-based precision diagnostics such as PET/CT scans, liquid biopsy (blood-based genetic tests) and detailed genetic panels. We use these leading diagnostic tools, combined with a thorough and personalized research review, as our team explores the most advanced scientific data available today to find the best options for you.
Other ways to stay in touch with CTOAM:
Facebook: https://www.facebook.com/CancerTreatmentOptionsandManagement/
LinkedIn: https://www.linkedin.com/company/ctoam
Twitter: https://twitter.com/CTOAM
Blog: https://research.ctoam.com/
LinkedIn (Liquid Biopsy Labs): https://www.linkedin.com/company/13063544
LBL Twitter: https://twitter.com/LiquidBiopsyNow
Disclaimer:
Please understand that these videos are meant for educational purposes only. These videos are not intended to diagnose or be used as treatment advice. Viewers are encouraged to speak with their doctor or healthcare professionals for medical advice and before making any changes to their healthcare based on this information. All statements made in this video regarding medical treatments and health conditions are sourced and have been approved by the U.S. Food and Drug Administration (FDA). Watching this video is not a substitute for professional medical advice or a diagnosis.
- Category
- Oncology

Be the first to comment